CR11069A - NON-PEPTIDIC MOLECULES FOR THE DETECTION AND TREATMENT OF TUMORS - Google Patents

NON-PEPTIDIC MOLECULES FOR THE DETECTION AND TREATMENT OF TUMORS

Info

Publication number
CR11069A
CR11069A CR11069A CR11069A CR11069A CR 11069 A CR11069 A CR 11069A CR 11069 A CR11069 A CR 11069A CR 11069 A CR11069 A CR 11069A CR 11069 A CR11069 A CR 11069A
Authority
CR
Costa Rica
Prior art keywords
tumors
detection
treatment
peptidic molecules
peptidic
Prior art date
Application number
CR11069A
Other languages
Spanish (es)
Inventor
E Summerton James
Original Assignee
E Summerton James
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2007/008215 external-priority patent/WO2007117398A2/en
Application filed by E Summerton James filed Critical E Summerton James
Publication of CR11069A publication Critical patent/CR11069A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Las oncotools son composiciones para detectar y tratar tumores que contienen areas hipoxicas/acidas caracteristicas de tumores malignos de tamano superior las microscopio. Las oncotool no tienen las propiedades de ser repelidas por las cedulas en tejidos normales.Oncotools are compositions for detecting and treating tumors that contain hypoxic / acidic areas characteristic of malignant tumors of a larger size under a microscope. Oncotool does not have the properties of being repelled by the cedulas in normal tissues.

CR11069A 2007-03-30 2009-10-19 NON-PEPTIDIC MOLECULES FOR THE DETECTION AND TREATMENT OF TUMORS CR11069A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2007/008215 WO2007117398A2 (en) 2006-03-30 2007-03-30 Non-peptidic molecules for detecting and treating tumors

Publications (1)

Publication Number Publication Date
CR11069A true CR11069A (en) 2009-11-20

Family

ID=39309976

Family Applications (1)

Application Number Title Priority Date Filing Date
CR11069A CR11069A (en) 2007-03-30 2009-10-19 NON-PEPTIDIC MOLECULES FOR THE DETECTION AND TREATMENT OF TUMORS

Country Status (5)

Country Link
AU (1) AU2007350326A1 (en)
CA (1) CA2682567A1 (en)
CR (1) CR11069A (en)
MX (1) MX2009010621A (en)
WO (1) WO2008121126A1 (en)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0952148B1 (en) * 1998-04-10 2004-05-12 Pfizer Products Inc. Cyclobutyl-aryloxyarylsulfonylamino hydroxamic acid derivatives
WO2001092273A2 (en) * 2000-05-30 2001-12-06 Guilford Pharmaceuticals Inc. Benzenedicarboxylic acid derivatives
JP3953923B2 (en) 2002-09-17 2007-08-08 カルソニックカンセイ株式会社 Electric motor and method for manufacturing electric motor
US7491718B2 (en) * 2002-10-08 2009-02-17 Abbott Laboratories Sulfonamides having antiangiogenic and anticancer activity
JP2006522744A (en) * 2003-04-11 2006-10-05 ノボ　ノルディスク　アクティーゼルスカブ Combination therapy using 11β-hydroxysteroid dehydrogenase type 1 inhibitor and glucocorticoid receptor agonist to minimize side effects associated with glucocorticoid receptor agonist therapy
US7285529B2 (en) * 2005-02-28 2007-10-23 Gene Tools, Llc Embedder compositions and methods for detecting and killing cells in acidic areas of tumors
US7132393B2 (en) 2005-02-28 2006-11-07 Gene Tools. Llc Transporter compositions and methods for detecting and killing cells in acidic areas of tumors
US20070231256A1 (en) * 2006-03-30 2007-10-04 Summerton James E Compositions and methods for detecting and treating tumors containing acidic areas
EP1998760A2 (en) * 2006-03-30 2008-12-10 James E. Summerton Non peptidic molecules for detecting and treating tumors

Also Published As

Publication number Publication date
WO2008121126A1 (en) 2008-10-09
CA2682567A1 (en) 2008-10-09
MX2009010621A (en) 2009-12-11
AU2007350326A1 (en) 2008-10-09

Similar Documents

Publication Publication Date Title
CY1125550T1 (en) CERTAIN TRIAZOLOPYRASINES, THEIR SYNTHESES AND METHODS FOR THEIR USE
MX2009008222A (en) Activin-actriia antagonists and uses for treating or preventing breast cancer.
EP2066694A4 (en) COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING CANCER
BRPI0712607A8 (en) stroke treatment methods
CY1115076T1 (en) ANTI-PDGFRα ANTIBODY FOR USE IN TREATMENT OF BREAST METHODS OF BONE
CY1119751T1 (en) MATERIALS AND METHODS FOR TREATMENT OR PREVENTION OF HER-3 DISEASES
BRPI0716210A2 (en) METHODS, COMPOSITIONS AND APPARATUS FOR TREATING WOUNDS WITH DIFFERENT PRESSURES OF THE ATMOSPHERIC
EP2350273A4 (en) GENETICALLY MODIFIED HUMAN ARGINASE COMPOSITIONS AND METHODS FOR TREATING CANCER
EP2571532A4 (en) IL-1 BINDING PROTEINS
EA201101521A1 (en) METHODS OF TREATMENT OF ONCOLOGICAL DISEASES, USING EPIMETABOLIC SWITCHES, MULTIPLE-DIFFERENT INTRACELLULAR MOLECULES OR IMPACT FACTORS
BRPI0908503A2 (en) particle less than 2mm in diameter, and composition for tissue treatment
NO20080626L (en) Inhibitors of fibroblast activating protein alpha
MX2009005058A (en) METHODS TO TREAT, DIAGNOSE, OR DETECT CANCER.
BRPI0921687A2 (en) Compound, conjugate, use of a compound, pharmaceutical composition, process for preparing a pharmaceutical composition, method for treating a mammal in need thereof, and method for treating or preventing a tumor in a mammal.
ECSP11011297A (en) ILL-17 BINDING PROTEINS
CL2008001076A1 (en) COMPOUNDS DERIVED FROM SULFONAMIDE; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF CANCER.
WO2007053573A3 (en) Treatment of cancer with sorafenib
WO2009036188A3 (en) Insulin-like growth factor binding protein 7 for treatment of cancer
BR112012011485A2 (en) "compositions and methods for treating centrally mediated nausea and vomiting".
BRPI0812737A2 (en) EQUIPMENT TO PREVENT AND TREAT PELVIC ORGAN PROLAPS.
EP2205189A4 (en) DEVICES AND METHODS FOR TREATING SPINAL CORD TISSUE
EP2214495A4 (en) NATURAL PHOTODYNAMIC AGENTS AND THEIR USE
ZA200708575B (en) Methods and compositions for treating or preventing cancer
EP2599497A3 (en) Porphyrazine-chemotherapeutic agents conjugates
BRPI0820802A2 (en) Materials and methods for treating pathological ocular vascular proliferation

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)